BIM Antibody | 45-330

BIM Antibody | 45-330 | Gentaur UK, US & Europe Distribution

Host: Goat

Reactivity: Human

Homology: N/A

Immunogen: The immunogen for this antibody is: C-FNAYYARRLEK

Research Area: Cancer

Tested Application: E, WB

Application: Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx 23kDa band observed in K562 lysates (predicted MW of 18.5kDa according to NP_619528.1) . Recommended for use at 0.5-2ug/ml.

Specificiy: This antibody is expected to recognise at least reported isoforms Bim-alpha1 (BimABCD) , Bim-alpha2 (BimACD) and Bim-alpha3 (BimAD) .

Positive Control 1: Cat. No. 1204 - K562 Cell Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Concentration: 500 ug/mL

Storage Condition: Aliquot and store at -20˚C. Minimize freezing and thawing.

Alternate Name: BCL2L11, BCL2-like 11 (apoptosis facilitator) , BAM, BIM, BOD, bcl-2 interacting mediator of cell death, bcl-2 interacting protein Bim, bcl-2-like protein 11, bcl-2-related ovarian death agonist, bcl2-L-11, Bim-alpha1, Bim-alpha2, Bim-alpha3

User Note: N/A

BACKGROUND: N/A